CDH1 and neoplasm: When examining E‐cadherin expression status, tumor budding was observed in 83.3% (15/18) of patients with weak (+) expression patterns, 41.9% (13/31) of patients with moderate (++) expression patterns, and 14.8% (4/27) of patients with high (+++) expression patterns.